Search

alt
0500

FiltersClear filters

Status
Sex
Age

Pfizer clinical trials

Search Results

We found 12 clinical trials for: Breast cancer,Breast Neoplasm, 150 miles

1 trial recruiting
Pfizer Breast Cancer Clinical Trials
Pfizer has several study medicines in development that may have the potential to help people with various types of breast cancer.
  • Breast cancer
  • Recruiting
2 trials recruiting
Be6A Clinical Trials
Evaluating sigvotatug vedotin to see if it will extend life expectancy and increase the period before cancer recurs.
  • Breast cancer
  • Recruiting
Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
  • Breast cancer
  • Recruiting
NCT07062965
Sex: All
Age: 18+
Locations: 433
View study
Recruiting
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
  • Breast cancer
  • Recruiting
NCT04557449
Sex: All
Age: 18+
Locations: 39
View study
Recruiting
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
  • Breast cancer
  • Recruiting
NCT07318805
Sex: All
Age: 18+
Locations: 17
View study
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
  • Breast cancer
  • Recruiting
NCT04606446
Sex: All
Age: 18+
Locations: 43
View study
Recruiting
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
  • Breast cancer
  • Recruiting
NCT05208762
Sex: All
Age: 18+
Locations: 62
View study
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
  • Breast cancer
  • Breast Neoplasm
  • Recruiting
NCT04879329
Sex: All
Age: 18+
Locations: 221
View study
Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
  • Breast cancer
  • Recruiting
NCT04389632
Sex: All
Age: 18+
Locations: 158
View study
Dec 01, 2026 - Planned start date (Not yet recruiting)
A Study of a Medicine Called Atirmociclib in Combination With Giredestrant in Adult Participants With ER-positive, HER2-negative Early-stage Breast Cancer
  • Breast cancer
  • Not yet recruiting
NCT07890597
Sex: All
Age: 18+
Locations: 0
View study
Nov 09, 2026 - Planned start date (Not yet recruiting)
A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors
  • Breast cancer
  • Not yet recruiting
NCT07897721
Sex: All
Age: 18+
Locations: 0
View study
Oct 21, 2026 - Planned start date (Not yet recruiting)
A Real-world Study to Learn About of the Characteristics and Outcomes of Advanced or Metastatic Bladder Cancer Patients With Different Histologies
  • Breast cancer
  • Not yet recruiting
NCT07897669
Sex: All
Age: 18+
Locations: 0
View study